ALKS

Alkermes plc (ALKS) Investor Outlook: Unlocking a 58.58% Potential Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, operates within the specialty and generic drug manufacturing industry. Headquartered in Dublin, Ireland, Alkermes has carved out a significant..

Alkermes plc (ALKS) Stock Analysis: A 40% Upside Potential Beckons Investors

Alkermes plc (NASDAQ: ALKS), a prominent player in the specialized pharmaceutical sector, offers a compelling opportunity for investors seeking exposure to the healthcare industry. As a biopharmaceutical company headquartered in..

Alkermes plc (ALKS) Stock Analysis: 35% Upside Potential and Strong Buy Ratings Boost Investor Outlook

Alkermes plc (ALKS), a prominent player in the healthcare sector, specializes in developing and commercializing pharmaceutical products tailored to address unmet medical needs. Headquartered in Dublin, Ireland, this biopharmaceutical company..

Alkermes plc (ALKS) Stock Analysis: Analyst Consensus Points to 42% Upside Potential

Alkermes plc (NASDAQ: ALKS), an Irish biopharmaceutical giant, is capturing the attention of investors with a compelling narrative. Operating within the Healthcare sector, specifically among Drug Manufacturers – Specialty &..

Alkermes plc (ALKS) Stock Analysis: Potential 42% Upside Amidst Strategic Developments

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, stands at the forefront of the biopharmaceutical industry, specifically within the specialties of drug manufacturing for both generic and proprietary products. With..

Alkermes plc (ALKS) Stock Analysis: Evaluating a 41% Potential Upside in the Biopharmaceutical Sphere

Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical industry, has garnered significant attention with a potential upside of 41.17%, as projected by analysts. Headquartered in Dublin, Ireland, Alkermes..

Alkermes plc (ALKS) Investor Outlook: Analyzing a 33.87% Upside in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company headquartered in Dublin, Ireland, is drawing attention from investors with its significant potential upside of 33.87%, as indicated by the average target price..

Alkermes plc (ALKS) Stock Analysis: Unlocking Potential with a 25.93% Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector specializing in drug manufacturing, has recently attracted attention from investors due to a promising potential upside of 25.93%. With..

Alkermes plc (ALKS) Investor Outlook: A 30.46% Potential Upside in the Dynamic Healthcare Sector

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, offers a compelling investment opportunity for those looking to capitalize on the biopharmaceutical industry’s growth. Headquartered in Dublin, Ireland,..

Alkermes plc (ALKS) Stock Analysis: Evaluating a 34.83% Potential Upside in the Healthcare Sector

Alkermes plc (NASDAQ: ALKS), based in Dublin, Ireland, is a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of..

Search

Funds

ALKS

Search

Funds

ALKS

FTSE 100

Funds